Under federal healthcare reform, who’ll be in charge of making treatment decisions? Will that continue to be a conversation between you and your practitioner, or will bureaucrats throttle us with rules and regulations?
Last week we updated you on our success in persuading the Senate to include integrative doctors in the Comparative Effectiveness Research (CER) program of the senate healthcare bill. This will make it harder for special interests to try to outlaw integrative medicine at the national level
The American Association for Health Freedom (soon to be The Alliance for Natural Health-USA thanks to our merger with The Alliance for Natural Health) has worked for months to gain recognition for integrated healthcare in President Obama’s Comparative Effectiveness Research (CER) plan (part of the stimulus bill) and in multiple iterations of healthcare reform legislation. […]
The Senate’s “Food Safety” bill is better than the House’s in some important respects. For example, it drops the draconian jail sentences and fines for vague infractions including paperwork errors. But it includes a Codex provision that absolutely must be removed by amendment in order to protect free choice about supplements. Please take action to […]
Thank you to our 801 advocates who used AAHF’s Action Center to submit comments in response to Docket Number FDA-200-N-0247, letting the Food and Drug Administration’s Transparency Task Force know that you support increased transparency at the FDA. On August 6, AAHF proudly hand-delivered 801 letters to the FDA’s Division of Docket Management. These comments […]
Nine French lawmakers, citing the ban by Canada and a number of U.S. states, have proposed legislation to ban bisphenol A (BPA) in all food containers (including baby bottles) setting the stage for France to become the first European country to ban BPA. In May, Denmark’s parliament passed a resolution calling on its government to […]
Alliance for Natural Health (ANH), the British counterpart to AAHF, has published a brilliant position paper on the marketing campaign being used to sell Splenda Mist.
An eye-opening article on the New York Times’ front page August 3, “Lack of Study Volunteers Hobbles Cancer Fight,” stated that just 3 percent of adult cancer patients participate in cancer-drug clinical trials. It also revealed that more than one in five trials sponsored by the National Cancer Institute fail to enroll a single subject with […]
Americans made a difference with dietary supplements/DSHEA. It’s time once again to tell legislators to preserve our healthcare freedom of choice.
The FDA reclassification moves dental amalgams from low risk (Class I) to moderate risk (Class II). Many dentists have already abandoned dental amalgam fillings, perhaps ringing the death knell for mercury fillings.